Gossamer Bio
GOSS
GOSS
127 hedge funds and large institutions have $688M invested in Gossamer Bio in 2021 Q3 according to their latest regulatory filings, with 23 funds opening new positions, 35 increasing their positions, 32 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
2.11% more ownership
Funds ownership: 69.94% → 72.05% (+2.1%)
9% more repeat investments, than reductions
Existing positions increased: 35 | Existing positions reduced: 32
1% more call options, than puts
Call options by funds: $5.41M | Put options by funds: $5.36M
Holders
127
Holding in Top 10
4
Calls
$5.41M
Puts
$5.36M
Top Buyers
| 1 | +$19.8M | |
| 2 | +$11.2M | |
| 3 | +$3.98M | |
| 4 |
IC
Ikarian Capital
Dallas,
Texas
|
+$3.82M |
| 5 |
EA
Emerald Advisers
Leola,
Pennsylvania
|
+$3M |
Top Sellers
| 1 | -$8.36M | |
| 2 | -$8.17M | |
| 3 | -$3.63M | |
| 4 |
SCM
Sio Capital Management
New York
|
-$2.12M |
| 5 |
Two Sigma Advisers
New York
|
-$1.95M |